A Phase I Study of the Safety, Reactogenicity, and Immunogenicity of Sm-TSP-2/Alhydrogel® With or Without GLA-AF for Intestinal Schistosomiasis in Healthy Adults

ClinicalTrials.gov (2017). A Phase I Study of the Safety, Reactogenicity, and Immunogenicity of Sm-TSP-2/Alhydrogel® With or Without GLA-AF for Intestinal Schistosomiasis in Healthy Adults.
Your Information
Your Comment
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
7 + 5 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.

Author nodes

Author full name Author id Edit
ClinicalTrials.gov 35374 edit